… This study investigated the cost effectiveness of early cardiac resynchronization therapy (CRT)
implantation among patients with mild heart failure (HF). The differential cost …

… economic outcomes of cardiac resynchronization therapy (CRT) versus optimal pharmacological
therapy (OPT) alone in patients with heart … economic appraisal of the economic value of …

… It appears that a series of factors, including financial issues (budget … to values around €15
000–20 000, but despite this positive trend financial barriers to widespread use of this therapy …

… financial resources and this is especially relevant for implementation of cardiac resynchronization
therapy (CRT), … Economic impact of cardiac resynchronization therapy in patients with …

… well as economic evaluations alongside … , cardiac resynchronization therapy device with
the addition of an implantable cardioverter-defibrillator; HF, heart failure; NYHA, New York Heart …

300 quences of ventricular dyssynchrony lead to rearrangement of both contractile and
noncontractile cellular elements and perhaps the extracellular matrix in the heart, thus …

… biventricular stimulation delivered by cardiac resynchronization therapy (CRT) improved LV
… The model took the economic perspective of the Center for Medicare and Medicaid Services …

… mortality, heart failure mortality and hospitalizations due to heart failure. … of cardiac
resynchronization therapy (CRT) with that of optimal drug therapy (ODT) by carrying out an economic …

… In line with the World Health Organization's suggestionCitation 44 , the economic thresholds
… Economic value and cost-effectiveness of biventricular versus right ventricular pacing: …

… heart failure, reduced left ventricular (LV) systolic function, and a wide QRS complex. Cardiac
resynchronization therapy … measures of the economic outcomes of new therapies, just as …